Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan T Chard

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Neurology|February 9, 2024
Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old FoeDeclan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2018
Commentary on Al Hussona et al. 'New-onset seizures as a sole clinical presentation of multiple sclerosis'Declan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2024
To halt disease progression rehabilitation in MS should start early: NoDeclan T Chard
Neurology|September 2, 2025
Diagnosing Multiple Sclerosis: An Imperfect but Evolving ProcessDeclan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 15, 2023
Clinical commentary on 'Cortical ischemic lesions from atrial myxoma as a mimic of disease activity in a RRMS antiCD20-treated patient'Declan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - NoDeclan T Chard, S Anand Trip
Neurology|August 21, 2009
What you see depends on how you look: Gray matter lesions in multiple sclerosisDeclan T Chard, David H Miller
Brain : a Journal of Neurology|January 10, 2016
What lies beneath grey matter atrophy in multiple sclerosis?Declan T Chard, David H Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2016
Visualization of cortical MS lesions with MRI need not be further improved - YESJeroen Jg Geurts, Declan T Chard
Expert Review of Neurotherapeutics|December 23, 2015
The role of MRI in the evaluation of secondary progressive multiple sclerosisJ William L Brown, Declan T Chard
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Neurology|February 9, 2024
Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old FoeDeclan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2018
Commentary on Al Hussona et al. 'New-onset seizures as a sole clinical presentation of multiple sclerosis'Declan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2024
To halt disease progression rehabilitation in MS should start early: NoDeclan T Chard
Neurology|September 2, 2025
Diagnosing Multiple Sclerosis: An Imperfect but Evolving ProcessDeclan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 15, 2023
Clinical commentary on 'Cortical ischemic lesions from atrial myxoma as a mimic of disease activity in a RRMS antiCD20-treated patient'Declan T Chard
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - NoDeclan T Chard, S Anand Trip
Neurology|August 21, 2009
What you see depends on how you look: Gray matter lesions in multiple sclerosisDeclan T Chard, David H Miller
Brain : a Journal of Neurology|January 10, 2016
What lies beneath grey matter atrophy in multiple sclerosis?Declan T Chard, David H Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2016
Visualization of cortical MS lesions with MRI need not be further improved - YESJeroen Jg Geurts, Declan T Chard
Expert Review of Neurotherapeutics|December 23, 2015
The role of MRI in the evaluation of secondary progressive multiple sclerosisJ William L Brown, Declan T Chard
Pageof 8